Abstract: An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.

Abstract: An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.

Abstract: The present invention provides a treatment agent composition for fiber products capable of producing an exceptional odor-eliminating and odor-preventing effect against various odors. This treatment agent composition for fiber products comprises: (A) highly branched cyclic dextrin; (B) at least one compound selected from the group consisting of an amine compound having within each molecule one to three C10-26 hydrocarbon groups optionally split with an ester group or an amide group, a salt of the amine compound, and a quaternized form of the amine compound; and (C) at least one compound selected from (C-1)-(C-3) below: (C-1) a fatty acid expressed by RaCOOH (Ra is a fatty acid represented by a C8-35 alkyl or alkenyl group), (C-2) a silicone compound, and (C-3) an aliphatic alcohol represented by RbOH (Rb is an aliphatic alcohol represented by a C8-35 alkyl or alkenyl group).

Abstract: The object of the present invention is to provide a marker substance capable of determining a risk of hyperglycemia in vivo with high accuracy. The present invention provides the following: a marker peptide for determining the risk of hyperglycemia; an antibody or an aptamer bound to the marker peptide for determining the risk of hyperglycemia; a microarray wherein the antibody or the aptamer to be bound to the marker peptide for determining the risk of hyperglycemia has been immobilized onto a carrier; a method of determining the risk of hyperglycemia wherein an amount or the presence/absence of the marker peptide for determining the risk of hyperglycemia is measured in a biological sample collected from a subject; and a kit for determining the risk of hyperglycemia comprising the antibody or the aptamer, or the microarray.

Abstract: It is an object of the present invention to provide a composition containing lactoferrin and another component and having a prominent effect of promoting visceral lipolysis. That is, the present invention is a composition for promoting the lipolysis; a food product, a feedstuff or a pharmaceutical product including (A) lactoferrin and (B) one or more ingredients selected from the group consisting of a Durvillaea extract, raspberry ketone, an artichoke leaf extract, a rosemary extract, isoflavone, a grape seed extract, a pine bark extract, a Coleus forskohlii extract, and a cacao extract. Also provided is a method of giving the effect of promoting the lipolysis to the food product or the feedstuff by adding the component (A) and the component (B) for promoting the lipolysis to the food product or the feedstuff.

Abstract: Disclosed is an ophthalmic composition which is characterized by containing (A) a vitamin A, (B) a polyoxyethylene polyoxypropylene glycol, and (C) an oil component that is selected from the group consisting of castor oil, soybean oil, sesame oil, peanut oil, olive oil, almond oil, wheat germ oil, corn oil, rapeseed oil, sunflower oil, purified lanolin and gel hydrocarbon.

Abstract: It is an object of the present invention to provide a marker substance capable of accurately determining a risk of developing metabolic syndrome in vivo. That is, the present invention provides the followings: a marker peptide for determining the risk of developing the metabolic syndrome; an antibody or an aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome; a microarray in which the antibody or the aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome has been immobilized on a carrier; a method for determining the risk of developing the metabolic syndrome, comprising measuring an amount or the presence or absence of the marker peptide for determining the risk of developing the metabolic syndrome in a biological sample collected from a subject; and a kit for determining the risk of developing the metabolic syndrome, comprising the antibody or the aptamer or comprising the microarray.

Abstract: An object of the present invention is to provide a sleep quality improving agent which has a sufficient sleep quality improving effect, can exert makes the effect even through oral administration in any dosage form, and has ensured safety to the body. That is, the present invention provides: a sleep quality improving agent which contains a stilbene-based compound and/or an olive extract as an active ingredient, and a sleep quality improving composition which contains the sleep quality improving agent.

Abstract: A liquid detergent composition containing (A) 10 to 70 mass % of a nonionic surfactant, (B) 1 to 15 mass % of an anionic surfactant, (C) 0.01 to 2 mass % of a protease, and (D) 0.001 to 0.1 mass % of at least one compound selected from the group consisting of thiazole-based compounds and sulfur-containing amino acids.

Abstract: Disclosed is an ophthalmic composition containing (A) not less than 50,000 units/100 mL of vitamin A, (B) not less than 0.4 W/V % of a polyoxyethylene polyoxypropylene glycol, and (C) trometamol.

Abstract: The present invention provides an oxidation catalyst for bleaching containing a component (a) which is an anion caused from a chelating agent having less than or equal to coordination position 5 and/or the chelating agent, and a component (b) which is a copper and/or manganese compound; and a binder compound (c); a hydrogen peroxide-based compound (d) which dissolves in water and generates hydrogen peroxide, the bleaching composition containing a granulated product or a molded product in which at least the component (b) and the component (c) are granulated or molded together. According to the invention, an oxidation catalyst that promotes the oxidation effect of hydrogen peroxide-based compounds with a trace amount of the composition, and has excellent effects of suppressing the decomposition of hydrogen peroxide-based compounds and suppressing coloration of the catalyst itself, and a bleaching composition containing the oxidation catalyst can be utilized.

Abstract: A process for producing a silane-modified cationized polymeric compound, the process including the steps of: (1) cationizing a water-soluble polymeric compound in a mixed solvent of a water-miscible organic solvent and water in the presence of an alkali to produce a slurry containing a cationized polymeric compound, (2) adding an aminosilane compound to the slurry or a cake produced therefrom, thereby treating the cationized polymeric compound with the aminosilane compound, (3) optionally adding an acid to the slurry obtained in step (1) or a product obtained in step (2), and (4) drying a product obtained in step (2) or a product obtained by performing step (3) after step (2), wherein the drying step (4) includes a primary drying treatment step of performing drying at a temperature of 50 to 140° C. under a degree of vacuum of 4.0 to 53.3 kPa, and a secondary drying treatment step of drying the product obtained following the primary drying treatment at a temperature of 90 to 155° C.

Abstract: A surfactant composition for agricultural chemicals, containing fatty acid polyoxyalkylene alkyl ether expressed by the following general formula (I), R1CO(EO)m(PO)nOR2??(I) wherein the fatty acid polyoxyalkylene alkyl ether has a narrow ratio of 55% by mass or more, where the narrow ratio is expressed by the following formula (A): Narrow ratio=?i=nMAX?2i=nMAX+2Yi??(A).

Abstract: Disclosed are a two-agent type disinfectant composition for hard articles, which includes a first agent containing a powder mixture (A) and a second agent containing an aqueous hydrogen peroxide solution (B-1), the powder mixture (A) containing an alkali metal salt (A-1) exhibiting basicity when the salt is in the form of an aqueous solution, a water-soluble copper salt (A-2), a compound (A-3) represented by the following formula (1), and a nonionic surfactant (A-4) represented by the following formula (2), and in which the molar ratio of the water-soluble copper salt (A-2) and the compound (A-3) represented by the mixing amount of (A-3)/mixing amount of (A-2) is 3.

Abstract: A neutral-fat-level-regulating agent, a cholesterol-level-regulating agent, a free-fatty-acid-level-regulating agent or an anti-obesity agent, including: at least one of protopanaxatriol, panaxatriol, protopanaxadiol and panaxadiol which are aglycons of dammarane-type saponins and a hyperlipemia-ameliorating agent including: at least one of the neutral-fat-level-regulating agent, the cholesterol-level-regulating agent, the free-fatty-acid-level-regulating agent and the anti-obesity agent.

Abstract: An object is to provide a sleep quality improving agent that can sufficiently exert the effect of improving the quality of sleep and ensures safety for the body. A sleep quality improving agent containing, as an effective ingredient, a plant of the Fraxinus genus such as Fraxinus excelsior L., an extract thereof, Larix sibirica extract, dihydroquercetin, dihydrokaempferol, or naringenin, and a sleep quality improving composition containing the sleep quality improving agent are provided.

Abstract: A cleaning composition which is capable of removing both organic soiling and particulate soiling adhered to a substrate for an electronic device with a high degree of cleanliness, and which also has minimal impact on the environment, as well as a method of cleaning a substrate for an electronic device. The present invention relates to a cleaning composition used for cleaning a substrate for an electronic device including a water-soluble salt (A) containing a transition metal, a chelating agent (B) and a peroxide (C), wherein the amount of the chelating agent (B) is not less than 0.5 molar equivalents relative to the amount of the water-soluble salt (A) containing a transition metal.

Abstract: An object is to provide a sleep quality improving agent that has a sufficient effect of improving the quality of sleep, can exert the effect regardless of the form of administration, even by oral administration, and ensures safety for the body. A sleep quality improving agent containing an S-adenosylmethionine-containing yeast as an effective ingredient and a sleep quality improving composition containing the sleep quality improving agent are provided.

Abstract: It is an object of the present invention to provide a growth hormone secretagogue that is excellent in effect of promoting secretion of a growth hormone and is orally available. The growth hormone secretagogue of the present invention contains one or more selected from the group consisting of S-adenosylmethionine and/or a salt thereof, a Siberian larch extract, an olive extract, and a stilbene-based compound as an active ingredient. S-adenosylmethionine and/or the salt thereof may be a form itself of chemically synthesized S-adenosylmethionine and/or the salt thereof, or may be a microbial cell or a culture containing S-adenosylmethionine and/or the salt thereof. The stilbene-based compound may be an extract extracted from a Vitaceae plant or a Gnetaceae plant. The olive extract may be an extract separated from a fruit of olive.

Abstract: A water-insoluble cutting fluid base oil or grinding fluid base oil for metalworking includes a fatty acid polyoxyalkylene alkyl ether represented by the following formula (I-A), wherein a hydroxyl value of the fatty acid polyoxyalkylene alkyl ether is less than or equal to 2.0 mgKOH/g. R1—CO-(OA)n-OR3??(I-A) (In the formula (I-A), R1 represents a linear or branched, saturated or unsaturated monovalent hydrocarbon group having 15 to 21 carbon atoms and R3 represents a linear, branched, or cyclic monovalent hydrocarbon group having 1 to 8 carbon atoms. In addition, A represents an alkylene group having 2 to 4 carbon atoms, OA represents alkylene oxide, and n represents 1 to 6 which is an average mole number of added alkylene oxide (AO)).